Paraclostridium benzoelyticum Bacterium-Mediated Zinc Oxide Nanoparticles and Their In Vivo Multiple Biological Applications

Table 2

Hypoglycemic activity of ZnO-NPs.

Groups	Dose	Blood glucose levels (mmol/L) fasting glucose levels	Glucose levels after 2 h	% of inhibition
Control distal water	1 mL/mice (oral)			—
NPs, mild dose	8 mg/kg b.w. (oral)		4	49.94
NPs, moderate dose	14 mg/kg b.w. (oral)			74.38
Standard: glibenclamide	10 mg/kg b.w. (oral)			48.12